| Literature DB >> 25400945 |
Vasiliki Panou1, Peter-Diedrich Mathias Jensen2, Jan Freddy Pedersen3, Lars Pilegaard Thomsen4, Ulla Møller Weinreich1.
Abstract
Hemoglobin Aalborg is a moderately unstable hemoglobin variant with no affiliation to serious hematological abnormality or major clinical symptoms under normal circumstances. Our index person was a healthy woman of 58, not previously diagnosed with hemoglobinopathy Aalborg, who developed acute respiratory failure after a routine cholecystectomy. Initially she was suspected of idiopathic interstitial lung disease, yet a series of tests uncovered various abnormal physiological parameters and set the diagnosis of hemoglobinopathy Aalborg. This led us to examine a group of the index person's relatives known with hemoglobinopathy Aalborg in order to study whether the same physiological abnormalities would be reencountered. They were all subjected to spirometry and body plethysmography, six-minute walking test, pulse oximetry, and arterial blood gas samples before and after the walking test. The entire study population presented the same physiological anomalies: reduction in diffusion capacity, and abnormalities in P(a)O2 and p50 values; the latter could not be presented by the arterial blood gas analyzer; furthermore there was concordance between pulse oximetry and arterial blood gas samples regarding saturation. These data suggest that, based upon the above mentioned anomalies in physiological parameters, the diagnosis of hemoglobinopathy Aalborg should be considered.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25400945 PMCID: PMC4221862 DOI: 10.1155/2014/701839
Source DB: PubMed Journal: Pulm Med ISSN: 2090-1844
Results of spirometry and body plethysmography, demonstrating forced expiratory volume in the 1st second in percent of expected value (FEV1%), forced ventilatory capacity in percent of expected value (FVC%), the ratio between FEV1 and FVC, and diffusing capacity of the lung for carbon monoxide in percent of expected value (DLCO%) and 6-minute walking tests in 7 patients with Hb Aalborg.
| Patient 1 (woman) | Patient 2 (man) | Patient 3 (woman) | Patient 4 (woman) | Patient 5 (woman) | Patient 6 (man) | Index person | |
|---|---|---|---|---|---|---|---|
| FEV1 (%) | 106 | 128 | 94 | 87 | 117 | 106 | 117 |
| FVC (%) | 108 | 122 | 103 | 107 | 104 | 98 | 134 |
| FEV1/FVC | 87 | 78 | 65 | 94 | 99 | 91 | 74 |
| DLCO (%) | 59 | 69 | 67 | 69 | 76 | 80 | 66 |
| Walking distance (m) | 417 | 480 | 562 | 420 | 568 | 551 | 273 |
Oxygen saturation, measured by pulse oximetry (spO2), and results from arterial blood gas analyses: arterial oxygen saturation (SaO2), partial pressure of oxygen (PaO2), oxygen tension at 50% saturated hemoglobin (P50), and hemoglobin, functional hemoglobin, and lactate concentration before and after 6-minute walking test in 7 patients with Hb Aalborg.
| Patient 1 (woman) | Patient 2 (man) | Patient 3 (woman) | Patient 4 (woman) | Patient 5 (woman) | Patient 6 (man) | Index person | |
|---|---|---|---|---|---|---|---|
| Before exercise | |||||||
| spO2 (%) | 83 | 79 | 85 | 73 | 85 | 69 | 87 |
| SaO2 (%) | 83.3 | 79 | 85.5 | 73.2 | 85 | 69.4 | 87.3 |
| PaO2 (mmHg) | 91.5 | 89.25 | 90.75 | 81 | 114.8 | 100.5 | 102.75 |
| P50 (mmHg) | 59.6 | 56.85 | 50.63 | 45.23 | 69.68 | 77.25 | 54.9 |
| Hemoglobin (g/dL) | 0.73 | 0.82 | 0.78 | 0.72 | 0.65 | 0.74 | 0.75 |
| Functional hemoglobin (g/dL) | 0.69 | 0.76 | 0.74 | 0.68 | 0.63 | 0.71 | 0.71 |
| Carboxyhemoglobin (g/dL) | 0.0037 | 0.0051 | 0.003 | 0.003 | 0.0015 | 0.005 | 0.0033 |
| Lactate ( | 8.11 | 8.11 | 5.41 | 5.41 | 15.3 | 9.91 | 9.91 |
|
| |||||||
| After exercise | |||||||
| spO2 (%) | 87 | 81 | 81 | 83 | 85 | 83 | 83 |
| SaO2 (%) | 87.5 | 81.7 | 81.5 | 83.2 | 85 | 83 | 82.9 |
| PaO2 (mmHg) | 91.5 | 96 | 93.75 | 102.75 | 91.5 | 112.5 | 96.75 |
| P50 (mmHg) | 47.85 | 58.8 | 57.9 | 61.28 | 51.68 | 68.85 | 54.23 |
| Hemoglobin (g/dL) | 0.73 | 0.82 | 0.78 | 0.74 | 0.69 | 0.74 | 0.77 |
| Functional hemoglobin (g/dL) | 0.69 | 0.77 | 0.74 | 0.70 | 0.62 | 0.72 | 0.73 |
| Carboxyhemoglobin (g/dL) | 0.0037 | 0.0043 | 0.0028 | 0.0036 | 0.003 | 0.0043 | 0.003 |
| Lactate ( | 15.32 | 8.11 | 6.31 | 9.91 | 7.21 | 9.91 | 9 |
Figure 1Explanations for reduction in DLCO: (a) normal physiology, (b) anemia, (c) high carboxyhemoglobin levels, (d) pulmonary disease (thickening of the alveolar membrane), (e) pulmonary vascular disease, and (f) Hb Aalborg.